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Patients presenting with ambiguous genitalia (AG)
often pose a dilemma to the attending clinicians as to
definite sex assignment. To avoid any doubt about
gender of rearing it is necessary that correct
diagnosis is made within a short period of birth.
Current hormonal and imaging studies for sex
determination could be supported by the application
of chromosomal and molecular genetic studies using
the SRY gene. Delay in diagnosis and treatment of
congenital adrenal hyperplasia (CAH) lead to adrenal
crisis. Moreover inappropriate gender assignment has
tragic consequences. Clinicians must be aware as
. .
well that pseudohypoaldosteronism can masquerade
as CAH and causes inappropriate hormonal therapy.
The SRY gene complements the investigations and
has aided us in patient management and counseling
ofparents. In the near future we are proceeding to the
analysis of the CYP21 gene to confirm diagnosis of
CAH due to 21- hydroxylase deficiency.
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The issue of correct gender assignment causes some.
amount of anxiety and the problem of acceptance on the
part of the parents. Patients with ambiguous genitalia
should be investigated for definite sex assignment.
Diagnosis will be aided by hormonal, imaging studies
and genetics information. Current clinical and hormonal
investigation protocols for sex determination could be
supported by the application of chromosomal and
molecular genetic studies using SRY gene as one of the
tools for gender assignment.
To apply molecular studies to complement
investigations for the genetic assignment of patient with
ambiguous genitalia.
Three patients were referred to Hospital Kota Bharu
(HKB) and Hospital Universiti Sains Malaysia (HUSM)
for further management of ambiguous genitalia. 3 - 5
ml blood specimen from the patients with ambiguous
genitalia was collected in sodium EDTA or lithium
heparin container. Blood was cultured for metaphase
cells for cytogenetic and FISH (Fluorescence in situ
hybridization) according to the standard protocol.
Genomic DNA was extracted and subjected to the
peR analysis of SRY gene using modified method
described earlier (1,2).
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Table 1
Tests/Patient I II III
Sodium 92 118 138**135-150 mmol/L
Potassium 7.4 8.2 5.5**3.5 - 5.0 mmol/L
>20 33.2 2.8 nmol/L* "17-0HP 3 mths-5 yrs :
«0.7-2.5) (normal for age)
up to 1.1 ng/ml
Cortisol 484 NA 67 nmoliL
am :139-501 (am: 221-690)
ACTH NO 50.7 pg/ml NO(N: <37)
<20 3.0 nmollLTestosterone NA (ng/dl) adult female: 0.9-2.8
>3,300 1,400 pmollL*
erect: 110-860Aldosterone (111-860 NA
supine: 30-440pmollL)
72.0 ng/mllh
PRA NA • NA erect: 1.3-4.0
supine:0.1-2.4
Karyotype 46,XX 46,XX 46,XX
SRY gene Not present Not present Not present
- Uterus. Bilateral pelvi-
US pelvis/abdomen Uterus and Uterus !Calyceal system
ovaries ~i1atation.Mildly
~istendedbladder.
Gen"itogram Figure 2 Figure 3 Not done
* results from overseas
** patient was on glucocorticoids and mineralocorticoids
NA: not available; NO : not done
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Severe neonatal jaundice. AG: I" CAH, salt loser
prominent phallus,
hyperpigmented labio-scrotal folds,
single orifice at the base of
phallus, no gonads palpable.
Reassigned as female.
Clitoris measures 2.5 cm
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PT
II
AGE
10 w
6d
9m
SEX
F
M
F
CLINICAL FEATURES
Failure to thrive. Adrenal crisis.
AG: phallus 2 em,
no gonads palpable, no rugae,
no hyperpigmentation, single
orifice at base of the phallus.
DIAGNOSIS
CAH, salt loser
THERAPY
G and M
G and M
COMPLICATION I PROGRESS
Undertreatment and poor compliance
caused virilisation, Patient was put
on high dose of glucocortlcoids to
suppress virilisation. At 6 years old,
she had fits and treated as
meningitis. Had hypertension and left
ventricular hypertrophy.
Sex reassignment at 6 months old.
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PT: patient, d: day, w: week, m: months, F: female, M: male, G: Glucocorticoids, M: mineralocorticoids, US: ultrasound, MCU :
micturating cystourethrogram '::;::;; I
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Bilateral pelvi-calyceal system
dilatation. Mildly distended urinary
bladder. Both abnormalities resolved
after one month. Normal electrolytes
after discontinuation of hormonal
treatment. Normal repeat US of
genitourinary system. Normal MCU.
G and MPseudohypoal-
dosteronism
AG: clitoris 0.9 cm
Slight hyperpigmentation and
scrotalisation of the medial aspect
of the labia majora. No palpable
gonads, no fusion of labia minora,
2 slit-like orifices seen. Mild
enlargement of adrenal glands.
F13 dIII
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Fig. 2 : Genitogram of patient I, both the bladder
and vagina (V) are opacified. Single perineal
opening with short segment urogenital sinus.
Fig. 4 : Ultrasound of the kidneys Qf patient III : Dilated
pelvicalyceal system of both kidneys (arrow).
Mild dilatation of urinary bladder. No adrenal mass- seen.
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Fig. 3 : Genitogram of patient II, the
urinary bladder (UBD) was filled with
contrast and normal in outline
':;,
Fig. 1 : External genitalia of patient
'. 'en'larged clitoris of 3.2 cm.
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Fig. 6:FISH with X chromosome.
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Fig. 8 : Multiplex peR of X,Y chromosome and SRY gene
specific regions.
M-100 bp DNA ladder ,
1-DNA sample from 46 XY with the presence of SRY gene
2- DNA sample from 46 XX
3- DNA sample from 46 XY with the absence of SRY gene
4-negative cont--l ( without DNA) ..-r -.
,."..-;)~~".-'.-'~ ~·A.\,~ ~.
Fig. 7:FISH with Y chromosome
Fig. 5 : US pelvis showing the uterus (UT) &
urinary bladder (USD).
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The presentation of the 3 patients illustrated the problem
encountered in managing AG/CAH. The diagnosis of CAH has to
be suspected and confirmed through investigations. Delay in
diagnosis and treatment of CAH lead to development of adrenal
crisis which can be life threatening (pt.1 & 2).
Inappropriate gender assignment has tragic consequences.
In a newborn baby with AG, sex assignment should not be
attempted until the results of appropriate investigations are
available. Patient 2 was assigned as male at birth but after the
AG was noted and investigated, patient was reassigned as
female. Sex confirmation through genetic studies includes
karyotyping and SRY gene.
Patient 3 was treated as CAH and relevant hormonal
investigations performed. From the results of the investigations
(table 1), pseudohypoaldosteronism was suspected. Urosepsis
was ruled out from the urine examination. However, the full blood
·picture showed reactive lymphocytes, 'thrombocytosis and an
umbilical swab showed a mixed growth of Gram negative bacilli
suggestive of a possible infection. Subsequent ultrasound of the
genitourinary system and electrolytes was normal after cessation
of hormonal medications. Pseudohypoaldosteronism can
masquarade as the salt losing type of CAH.
Imaging studies can aid in identifying the uterus (fig.5) and
gonads. Genitogram will identify the anatomy of the genitourinary
system (fig. 2&3), which is important for future surgical
.correction. Clitoroplasty was not performed in patient I due to
parents' poor understanding of the importance' of surgical
correction.
Close monitoring- of the patient is needed to ensure that
virilisation or hypertension did not occur due to under or
overdosage of hormonal therapy respectively.
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Molecular studies complement hormonal and imaging
studies for sex confirmation and appropriate sex assignment
or reassignment. Regular medical assessment and
monitoring of treatment is the key to the successful
management of CAH. Pseudohypoaldosteronism is another
differentjal diagnosis to be thought of in cases of electrolyte
imbalances that causes inappropriate hormonal therapy.
Counseling of the parents is important· to avoid
mismanagement, complication and psychosocial issues. We
intend to study the CYP21 gene rearrangement to confirm
diagnosis of CAH in those patients presenting with AG.
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